Multimodal intervention approach shows promise in managing and reversing cognitive impairment

Dr. Heather Sandison, a leading expert in Alzheimer’s Disease and Related Dementia (ADRD) care, has recently published a groundbreaking study in the Journal of Alzheimer’s Disease, highlighting significant improvements in cognitive function among individuals with cognitive decline.

Novartis’ urticaria drug meets all endpoints in Phase III trials – Pharmaceutical Technology

Remibrutinib is forecasted to generate $237m in 2034 in US sales, as per GlobalData’s Expiry model. Image Credit: Michael Derrer Fuchs / Shutterstock. Novartis’ remibrutinib

November 10, 2023

Opinion | The Risks of Universal Water Fluoridation and ‘No Known Harm’

Hassan is an instructor in pediatrics. “The fluoride in our water is completely safe,” I heard myself saying with practiced confidence. As has become increasingly

March 15, 2025

Study uncovers novel genetic variant associated with intellectual disability

Researchers at the Icahn School of Medicine at Mount Sinai have published a pivotal study in Nature Genetics (DOI: 10.1038/s41588-024-01917-1) that sheds light on a

September 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.